MODUS and SAFEBOD Publications

by Organ Donation Evidence | Nov 27, 2023 | All Research Output, MODUS, SAFEBOD

Cost-effectiveness of Interventions to Increase Utilization of Kidneys From Deceased Donors With Primary Brain Malignancy in an Australian Setting Kidneys from potential deceased donors with brain cancer are often foregone due to concerns of cancer transmission risk...

CELESTIAL Publications

by Organ Donation Evidence | Nov 27, 2023 | All Research Output, CELESTIAL

Cause of death for people with end-stage kidney disease withdrawing from treatment in Australia and New Zealand Our study objective was to estimate treatment withdrawal death rates within the Australian and New Zealand ESKD population, as well as to compare the...

Sex differences in associations between creatinine and cystatin C-based kidney function measures with stroke and major bleeding

by Organ Donation Evidence | Nov 27, 2023 | All Research Output, SHE-ROCKS

We sought to explore whether adding kidney function biomarkers based on creatinine (eGFRCr), cystatin C (eGFRCys) or a combination of the two (eGFRCr-Cys) could improve risk stratification for stroke and major bleeding, and whether there were sex differences in any...

53rd National Congress of the Spanish Nephrology Society

by Organ Donation Evidence | Nov 19, 2023 | News & Events

Well done Laia Oliveras Pages on her work “Relative Cancer Survival in Dialysis and Transplant Patients” presented at the 53rd National Congress of the Spanish Nephrology Society (S.E.N) in Mallorca.

Congratulations to Mel Wyld!

by Organ Donation Evidence | Sep 21, 2023 | News & Events

Congratulations to Melanie Wyld for her study featuring in “Best of ASN Journals: JASN, CJASN and Kidney360” session at Kidney Week 2023! Read paper here: Life years lost in children with kidney failure